If the regulator can now review its watch-list every three months, how ready is your operation on any given day?
The regulatory temperature in Australia has risen again. The Therapeutic Goods Administration (TGA) has named TGA medicinal cannabis as one of its priority focus areas for the 2026-27 compliance program, and on 7 July 2026 it issued new compliance guidance covering medicinal cannabis vaping devices.[1][2] Neither move rewrites the rulebook, but together they signal tighter, more frequent scrutiny for cultivators, manufacturers and importers.
TGA Medicinal Cannabis Is Now a Named Compliance Priority
On 22 January 2026 the TGA published its Compliance Principles for 2026 and 2027, setting out how it will monitor and enforce the import, export, manufacture, supply and advertising of therapeutic goods.[1] Medicinal cannabis appears as one of 12 named priority focus areas, listed alphabetically alongside vaping goods, weight-loss medications and melatonin.[1][3] It is a named priority, not a ranked “number one” target, but its inclusion puts the sector under standing attention rather than periodic review.
These two cadences are easy to conflate. The practical takeaway is that the list of what the TGA is actively watching can shift every three months, and medicinal cannabis is on it now. Professor Anthony Lawler, who heads the TGA, has publicly framed the program as taking firm, proportionate action when the rules are ignored.[1]
What Does the New Vaping-Device Checklist Require?
The genuinely new development this month sits on a distinct compliance surface: the hardware. Medicinal cannabis vaping devices, including unfilled vaporisers, tanks, mouthpieces, seal rings, 510 batteries and empty cartridges or pods intended to be filled, are regulated as medical devices, separate from the cannabis substance itself.[2][4]
On 7 July 2026 the TGA published a checklist (V1.0) to help sponsors and manufacturers identify the industry standards and evidence needed to show a vaping device meets the Essential Principles of Safety and Performance.[2] It notes there is no single standard that covers everything, so manufacturers will usually need to apply a combination of standards. Importantly, the checklist does not introduce new regulatory requirements; it consolidates existing expectations and supports demonstrating compliance with current rules.[2] The same day, the TGA refreshed its guidance for importers, exporters and manufacturers on product quality, manufacturing standards and reporting for these devices, a page previously updated in early 2025.[4]
| What is new in 2026 | Date | What it means |
|---|---|---|
| Medicinal cannabis named a priority focus area | 22 Jan 2026 | Standing attention, reviewed quarterly through 2026-27 |
| Vaping-device Essential Principles checklist (V1.0) | 7 Jul 2026 | Consolidated benchmark for device evidence; no new law |
| Refreshed importer/manufacturer device guidance | 7 Jul 2026 | Clearer quality, manufacturing and reporting expectations |
What This Means for Producers and Importers
The message is continuity of scrutiny, not a new statute. With quarterly focus-area reviews and principles that emphasise digital capability and stronger enforcement, the TGA is actively scanning websites, e-commerce and social channels.[1] Device manufacturers now have a clearer, consolidated benchmark against which their Essential-Principles evidence will be judged, and importers still need Office of Drug Control licences and permits, with false or misleading compliance notices carrying criminal exposure.[4]
None of this replaces the substance-side obligations you already know. Our existing guides on TGO 93 testing limits and ODC quarterly reporting still apply. The shift is posture and frequency: be continuously audit-ready, not reactively so.
How GrowerIQ Fits In
As scrutiny becomes more frequent and intelligence-led, the operators who cope best are those whose records are always current. GrowerIQ’s seed-to-sale traceability, built-in quality management system with CAPAs, deviation reports and SOP management, and batch-level tracking help keep quality and compliance evidence inspection-ready at any time. That readiness is a general operating advantage under a quarterly-review regime, not a substitute for the device-specific Essential-Principles work.
Key Takeaways
- Named priority: TGA medicinal cannabis is one of 12 priority focus areas for 2026-27 (published 22 January 2026), reviewed quarterly.
- New device guidance: a 7 July 2026 checklist consolidates the Essential Principles evidence expected for medicinal cannabis vaping devices.
- No new law: the checklist adds no new requirements; it clarifies existing ones and signals tighter scrutiny.
- Devices are separate: vaping hardware is regulated as a medical device, distinct from the cannabis substance.
Frequently Asked Questions
Is medicinal cannabis a TGA compliance priority in 2026?
Yes. The TGA named medicinal cannabis as one of 12 priority focus areas in its Compliance Principles for 2026 and 2027, published on 22 January 2026. It is a named focus area, not a ranked number-one target, and the focus areas are reviewed quarterly.
Did the 7 July 2026 vaping-device checklist create new rules?
No. The TGA states the checklist does not introduce new regulatory requirements. It consolidates existing expectations and helps manufacturers show that a medicinal cannabis vaping device meets the Essential Principles of Safety and Performance.
Are medicinal cannabis vaping devices regulated separately from the cannabis?
Yes. The vaping hardware, including unfilled vaporisers, tanks, batteries and empty cartridges, is regulated as a medical device, separate from the medicinal cannabis substance it delivers.
Last updated: July 2026
Ready to stay inspection-ready under quarterly TGA reviews?
See how GrowerIQ keeps Australian producers’ quality and compliance records audit-ready every day, not just at reporting time.
REQUEST DEMO
Sources
- TGA releases compliance principles reinforcing proactive and risk-based enforcement throughout 2026 and 2027 (accessed 17 July 2026)
- Industry standards and guidance documents for medicinal cannabis vaping devices, TGA (accessed 17 July 2026)
- Clayton Utz: TGA’s compliance principles for 2026 and 2027 (accessed 17 July 2026)
- Medicinal cannabis vaping devices: information for importers, exporters and manufacturers, TGA (accessed 17 July 2026)
About GrowerIQ
GrowerIQ is changing the way producers use software - transforming a regulatory requirement into a robust platform to learn, analyze, and improve performance.
To find out more about GrowerIQ and how we can help, fill out the form to the right, start a chat, or contact us.